Chandran A U, Rennie R
Medical Microbiology Laboratory, University of Alberta Hospital, Edmonton, Canada.
Clin Microbiol Infect. 2005 Dec;11(12):1037-40. doi: 10.1111/j.1469-0691.2005.01278.x.
The clinical significance of discontinuing routine antibiotic susceptibility testing (AST) of coagulase-negative Staphylococcus (CNS) isolates from blood cultures was investigated. Prospectively, AST was requested primarily for patients with serious underlying illnesses. Antibiotic use did not change significantly when AST was not performed routinely. Laboratory cost savings were 75% if AST was not performed, but more specimens were submitted from these patients. Oxacillin resistance in coagulase-negative staphylococci from blood cultures has remained > 70% since implementation of this protocol, while annual vancomycin utilisation has shown only small, incremental increases. Therefore, it is suggested that routine AST of CNS isolates from blood culture is not essential.
研究了停止对血培养中凝固酶阴性葡萄球菌(CNS)分离株进行常规药敏试验(AST)的临床意义。前瞻性地,主要对患有严重基础疾病的患者进行AST检测。不进行常规AST检测时,抗生素使用情况无显著变化。如果不进行AST检测,实验室成本可节省75%,但这些患者提交的标本更多。自实施该方案以来,血培养中凝固酶阴性葡萄球菌对苯唑西林的耐药率一直>70%,而每年万古霉素的使用量仅呈小幅递增。因此,建议对血培养中的CNS分离株进行常规AST检测并非必要。